Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
Abstract Objective Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has been recommended to treat critical coronavirus disease 2019 (COVID‐19) patients in a few reviews, but the clinical study evid...
Main Authors: | Ziyun Shao, Yongwen Feng, Li Zhong, Qifeng Xie, Ming Lei, Zheying Liu, Conglin Wang, Jingjing Ji, Huiheng Liu, Zhengtao Gu, Zhongwei Hu, Lei Su, Ming Wu, Zhifeng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Clinical & Translational Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1002/cti2.1192 |
Similar Items
-
The Production Processes and Biological Effects of Intravenous Immunoglobulin
by: Ana Filipa Barahona Afonso, et al.
Published: (2016-03-01) -
Hemolysis induced cross-matching difficulty with intravenous immunoglobulin: a case report
by: Achyut Sharma, et al.
Published: (2018-09-01) -
The use of intravenous immunoglobulin in pediatric rheumatology
by: Zbigniew Żuber, et al.
Published: (2014-07-01) -
Multimodality treatment in immunocompromised patients with severe COVID‐19: the role of IL‐6 inhibitor, intravenous immunoglobulin, and haemoperfusion
by: Nophol Leelayuwatanakul, et al.
Published: (2021-04-01) -
Intravenous immunoglobulin-associated hemolysis: risk factors, challenges, and solutions
by: Mohamed M
Published: (2016-10-01)